ExQor DuoThera
Photonic Assist

  • ExQor DuoThera(tm) Photonic Assist is a complementary photonic therapy and diagnostic solution for its CNS drug transporter. It complements ExQor's core mission of enabling and enhancing drug delivery to the central nervous system for the worldwide benefit of the pharmaceutical and biotech industries.

  • CNS cancer cells, damaged neurons, regulatory organs in the brain that control diabetes and psychiatric illness, plaques associated with Alzheimer's, and DNA are just some CNS elements and conditions shown to be responsive to light or to light-assisted drug therapies. But almost all current photonic medical solutions for the CNS are invasive or toxic.

  • Built on the same platform as ExQor's CNS drug transporter, ExQor's DuoThera system combines non-invasive large and small drug delivery to the brain with non-toxic and non-invasive medical light therapy. The result is a new dimension in CNS therapeutics and diagnostics.

  • DuoThera can provide an increase in drug efficacy as well as offering new therapeutic targets in the CNS. A complete payload including macromolecule CNS drug cargo and DuoThera photonic assist can be 50nm or even smaller in size.

  • DuoThera CNS solutions range from non-toxic fluorescent agents to a complete nanoscale solution for in situ low level laser light therapy used in conjunction with CNS therapeutic and diagnostic agents.

  • ExQor's patented photonic bio-nanotechnology non-invasively crosses an intact blood brain barrier, just like its patented CNS drug transporter.